Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 12, keine Gesamtzahl für „occurring“
Suchtreffer
Begriffe & Kennungen
Tecartus · 4.8 · The most significant and frequently occurring adverse reactions were CRS (91%), encephalopathy (57%), and infe
Eintrag öffnenTecartus · 4.8 · The most significant and frequently occurring adverse reactions were CRS (91%), infections (55%) and encephalo
Eintrag öffnenTecentriq · 4.8 · 85 Table 3: Summary of adverse reactions occurring in patients treated with atezolizumab
Eintrag öffnenTecentriq · 4.8 · Table 3: Summary of adverse reactions occurring in patients treated with atezolizumab
Eintrag öffnenTeizeild · 4.8 · The adverse reactions occurring in patients in the pooled safety analysis of clinical studies and post- market
Eintrag öffnenTepkinly · 4.8 · Adverse reactions occurring with epcoritamab are listed in Table 8.
Eintrag öffnenTepkinly · 4.8 · Adverse reactions occurring with epcoritamab are listed in Table 8.
Eintrag öffnenTepkinly · 4.8 · Adverse reactions occurring with epcoritamab in combination with lenalidomide and rituximab are listed in Tabl
Eintrag öffnenTepkinly · 4.8 · Adverse reactions occurring with epcoritamab in combination with lenalidomide and rituximab are listed in Tabl
Eintrag öffnenThyrogen · 4.8 · Summary of the safety profile The most commonly reported adverse reactions are nausea and headache, occurring
Eintrag öffnenTolucombi · 4.8 · Adverse reactions reported in all clinical trials and occurring more frequently (p ≤ 0.05) with telmisartan pl
Eintrag öffnenTolucombi · 4.8 · Adverse reactions reported in all clinical trials and occurring more frequently (p ≤ 0.05) with telmisartan pl
Eintrag öffnenTorisel · 4.5 · An increased incidence of angioneurotic oedema (including delayed reactions occurring two months following ini
Eintrag öffnenTosmova (previously Tocilizumab STADA and Tofidence) · 4.8 · 14 Table 3. List of adverse reactions occurring in clinical trial patients with sJIA or pJIA receiving tociliz
Eintrag öffnenTosmova (previously Tocilizumab STADA and Tofidence) · 4.8 · Infusion-related reactions In pJIA patients, infusion-related reactions are defined as all events occurring du
Eintrag öffnenTosmova (previously Tocilizumab STADA and Tofidence) · 4.8 · Infusion-related reactions Infusion-related reactions are defined as all events occurring during or within 24
Eintrag öffnenTosmova (previously Tocilizumab STADA and Tofidence) · 4.8 · Table 1. List of adverse reactions occurring in patients with RA receiving tocilizumab as monotherapy or in co
Eintrag öffnenTosmova (previously Tocilizumab STADA and Tofidence) · 4.8 · The rate of anaphylactic reactions (occurring in a total of 8/4 009 patients, 0.2%) was several fold higher wi
Eintrag öffnenTrodelvy · 4.8 · Adverse reactions occurring in patients treated with sacituzumab govitecan in combination with pembrolizumab w
Eintrag öffnenTruxima · 4.8 · Table 5 Adverse reactions occurring at 6-months in ≥ 5% of adult patients receiving rituximab in GPA/MPA Study
Eintrag öffnen